It may be impossible to use a vaccine to tackle Democratic Republic of Congo's new Ebola outbreak that has caused four confirmed cases, including two health workers, a senior World Health Organization (WHO) official said.
All news from Tropical Medicine
The need to embrace technology to radically improve how the NHS successfully delivers its services is behind a new partnership between the University of Essex and Provide CIC.
PROGGA, a leading anti-tobacco group in Bangladesh, said Japan Tobacco’s presence will “increase the risk of public health since the company will invest a huge amount of money to market their lethal products”.
Increasing taxes on alcohol is one of the most cost-effective methods of reducing the harms caused by alcohol consumption, according to research in the new issue of the Journal of Studies on Alcohol and Drugs.
Researchers have developed another novel statistical method for evaluating gene-to-gene interactions associated with cancer and other complex diseases. The Additive-Additive 9 Interaction (AA9int) method is described in a paper published in Bioinformatics. "This method can identify combinations of genetic variants for predicting cancer risk and prognosis," notes Dr. Lin, who is also the paper's lead author.
Patient associations lauded an EU decision to allow the sale of generic versions of Truvada, an anti-retroviral medicine used by those diagnosed HIV-positive, the virus causing AIDS.
New University at Buffalo research is adding important information to the body of knowledge about the cognitive and behavioral status of a group of retired professional athletes who spent their careers in contact sports.
The US Food and Drug Administration's (FDA's) Pulmonary-Allergy Drugs Advisory Committee voted overwhelmingly not to recommend (no-16, yes-3) mepolizumab (Nucala, GlaxoSmithKline) "as add-on treatment to inhaled corticosteroid-based maintenance treatment for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD) guided by blood eosinophil counts."
The Committee for Medicinal Products for Human Use of the European Medicines Agency voted on July 26 to recommend the combination treatment tezacaftor 100 mg and ivacaftor 150 mg (Symkevi, Vertex Pharmaceuticals [Europe]) for patients aged 12 years and older who have an underlying cause of cystic fibrosis (CF).
SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, announced that its anti-Ebola immunotherapy (SAB-139) provided "100% protection against a lethal dose of the Ebola virus" in a recent animal study published in The Journal of Infectious Diseases.
Transgenic males of Aedes aegypti with defective sperm have been created at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil and may be produced on a pilot scale next year. Alongside the development of vaccines, the production of genetically modified mosquitoes could become one of the most effective means of combating epidemics of dengue, chikungunya, Zika and yellow fever.
Elderly individuals with fewer teeth, poor dental hygiene, and more cavities constantly ingest more dysbiotic microbiota, which could be harmful to their respiratory health, according to new research published in the journal mSphere. The findings come from a large, population-based study that identified variations in the tongue microbiota among community-dwelling elderly adults in Japan.